Shuster Lewis 4
4 · Principia Biopharma Inc. · Filed Jan 10, 2019
Insider Transaction Report
Form 4
Shuster Lewis
Director
Transactions
- Award
Director Stock Option (right to buy)
2018-09-13+20,475→ 20,475 totalExercise: $17.00Exp: 2028-09-12→ Common Stock (20,475 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over a three year period, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.